In this short article, the author states that there were

New Post Public Reply Private Reply Replies (1) Message Board
Buddyboy20 chazzledazzle #141533
669
In this short article, the author states that there were current studies, in progress at UCLA, that were using Maraviroc to see if it would improve cognition. I haven't seen anything showing results yet. However, there should be something out soon. There are a lot of peer reviewed papers that show CCR5 as a prime therapeutic target in Alzheimer's Disease.


MIT Technology Review
SUBSCRIBE

BLOCKCHAIN
China’s CRISPR twins might have had their brains inadvertently enhanced
New research suggests that a controversial gene-editing experiment to make children resistant to HIV may also have enhanced their ability to learn and form memories.
By Antonio Regaladoarchive page
February 21, 2019

JOHN UELAND
The brains of two genetically edited girls born in China last year may have been changed in ways that enhance cognition and memory, scientists say.

The twins, called Lulu and Nana, reportedly had their genes modified before birth by a Chinese scientific team using the new editing tool CRISPR. The goal was to make the girls immune to infection by HIV, the virus that causes AIDS.

Advertisement

Now, new research shows that the same alteration introduced into the girls’ DNA, deletion of a gene called CCR5, not only makes mice smarter but also improves human brain recovery after stroke, and could be linked to greater success in school.

“The answer is likely yes, it did affect their brains,” says Alcino J. Silva, a neurobiologist at the University of California, Los Angeles, whose lab uncovered a major new role for the CCR5 gene in memory and the brain’s ability to form new connections.

“The simplest interpretation is that those mutations will probably have an impact on cognitive function in the twins,” says Silva. He says the exact effect on the girls’ cognition is impossible to predict, and “that is why it should not be done.”

Photo of Dr. Jiankui He
He Jiankui poses for the cameras of the Associated Press in the days before his gene-editing experiments became known.
Mark Schiefelbein | AP
The Chinese team, led by He Jiankui of the Southern University of Science and Technology in Shenzhen, claimed it used CRISPR to delete CCR5 from human embryos, some of which were later used to create pregnancies. HIV requires the CCR5 gene to enter human blood cells.


The experiment has been widely condemned as irresponsible, and He is under investigation in China. News of the first gene-edited babies also inflamed speculation about whether CRISPR technology could one day be used to create super-intelligent humans, perhaps as part of a biotechnology race between the US and China.

There is no evidence that He actually set out to modify the twins’ intelligence. MIT Technology Review contacted scientists studying the effects of CCR5 on cognition, and they say the Chinese scientist never reached out to them, as he did to others from whom he hoped to get scientific advice or support.

“As far as I know, we never heard from him,” says Miou Zhou, a professor at the Western University of Health Sciences in California.

Although He never consulted the brain researchers, the Chinese scientist was certainly aware of the link between CCR5 and cognition. It was first shown in 2016 by Zhou and Silva, who found that removing the gene from mice significantly improved their memory. The team had looked at more than 140 different genetic alterations to find which made mice smarter.

Advertisement

Silva says because of his research, he sometimes interacts with figures in Silicon Valley and elsewhere who have, in his opinion, an unhealthy interest in designer babies with better brains. That’s why, when the birth of the twins became public on November 25, Silva says he immediately wondered if it had been an attempt at this kind of alteration. “I suddenly realized—Oh, holy shit, they are really serious about this bullshit,” says Silva. “My reaction was visceral repulsion and sadness.”

During a summit of gene editing scientists that occurred two days later in Hong Kong, He acknowledged he had known all along about the potential brain effects from the UCLA research. “I saw that paper, it needs more independent verification,” He replied when asked about it during a Q&A session (see video here). He added: “I am against using genome editing for enhancement.”

Whatever He’s true aims, evidence continues to build that CCR5 plays a major role in the brain. Today, for example, Silva and a large team from the US and Israel say they have new proof that CCR5 acts as a suppressor of memories and synaptic connections.

According to their new report, appearing in the journal Cell, people who naturally lack CCR5 recover more quickly from strokes. What’s more, people missing at least one copy of the gene seem to go further in school, suggesting a possible role in everyday intelligence.


“We are the first to report a function of CCR5 in the human brain, and the first to report a higher level of education,” says UCLA biologist S. Thomas Carmichael, who led the new study. He calls the link to educational success “tantalizing” but says it needs further study.

The discoveries about CCR5 are already being followed up in drug trials on both stroke patients and people with HIV, who sometimes suffer memory problems. In those studies, one of which is under way at UCLA, people are being given an anti-HIV drug, Maraviroc, which chemically blocks CCR5, to see if it improves their cognition.

Silva says there is a big difference between trying to correct deficits in such patients and trying to create enhancement. “Cognitive problems are one of the biggest unmet needs in medicine. We need drugs, but it’s another thing to take normal people and muck with the DNA or chemistry to improve them,” he says. “We simply don’t know enough to do it. Nature has struck a very fine balance.”

Just because we shouldn’t alter normal intelligence doesn’t mean we can’t. Silva says the genetic manipulations used to make “smart mice” show not only that it is possible, but that changing CCR5 has particularly big effects.

“Could it be conceivable that at one point in the future we could increase the average IQ of the population? I would not be a scientist if I said no. The work in mice demonstrates the answer may be yes,” he says. “But mice are not people. We simply don’t know what the consequences will be in mucking around. We are not ready for it yet.”

by Antonio Regalado
linkedinlink opens in a new window
twitterlink opens in a new window
facebooklink opens in a new window
emaillink opens in a new window

KEEP READING
MOST POPULAR
This new data poisoning tool lets artists fight back against generative AI
The tool, called Nightshade, messes up training data in ways that could cause serious damage to image-generating AI models.

By Melissa Heikkiläarchive page
Rogue superintelligence and merging with machines: Inside the mind of OpenAI’s chief scientist
An exclusive conversation with Ilya Sutskever on his fears for the future of AI and why they’ve made him change the focus of his life’s work.

By Will Douglas Heavenarchive page
Data analytics reveal real business value
Sophisticated analytics tools mine insights from data, optimizing operational processes across the enterprise.

By MIT Technology Review Insightsarchive page
Driving companywide efficiencies with AI
Advanced AI and ML capabilities revolutionize how administrative and operations tasks are done.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Global Mayors Dialogue 2026: Ningbo Leads in Urban Ideas

Updated Category News Views 153

New Waves in City Collaboration Get this: from November 2 to 5, Ningbo, a key city nestled in east China's Zhejiang Province, is rolling out the red carpet for the 2026 Global Mayors Dialogue. Nearly 200 influential figures zooming into this seaside city isn't just for some aimless chit-chat. At the core, the theme is "Openness and Connectivity for Shared Opportunities."...

Continue Reading
Check Point Q3 2026 Results: Subtle Shifts or a Turning Point?

Updated Category News Views 176

Digging Deeper into Check Point's Latest Figures When Check Point Software Technologies Ltd. (NASDAQ:CHKP) throws numbers at the wall, not everything sticks, but there's always something telling. The Q3 financial results for 2026 are out, and it's a mixed bag—coffee’s getting cold before you parse through it. Revenue and Subscription Dynamics Let's cut to it: total...

Continue Reading
Platinum Equity's Bold Move on Warren Valve: An Analysis

Updated Category News Views 51

A Big Play in the Valve Game Straight out of the industrial playbook, Platinum Equity swoops in with its latest acquisition of Warren Valve, yanking it from the clutches of Allied Group. It's not every day you see a move like this in the flow control world. Yeah, you heard that right—flow control. The kind of business that’s all about ensuring the right stuff gets to...

Continue Reading
Pak Mail Jonesboro Dominates at Annex Brands Convention

Updated Category News Views 44

Small Town, Big Impact at the Annex Brands Shindig From little Jonesboro, Arkansas, comes a thunderous clap for the Kincades, who bagged a bunch of trophies and accolades at the big 2026 Annex Brands National Convention. Tim and Rhonda Kincade, the ones running Pak Mail Jonesboro, didn't just show up—they brought home the bacon with honors piled as high as the Ozarks....

Continue Reading
Anthropic's IPO Spurs Leverage Shares' New ETFs

Updated Category News Views 51

Taking a Gamble on AI's New Kid on the Block Here we stand on the edge of another potential AI stock bonanza. Anthropic’s got its sights set on going public, and folks are lining up to bite into what could be the next big generative AI feast. But it's Leverage Shares by Themes that's setting the scene for something a bit wilder—introducing some juicy leveraged and...

Continue Reading
Paulex Bio's PAL-119 Trials: A New Diabetes Frontier

Updated Category News Views 80

Chasing the Holy Grail in Diabetes Treatment The pursuit of a true remedy for diabetes is almost like hunting for the mythical beast—a challenge that's left plenty of contenders biting the dust over the years. Yet, here's Paulex Bio jumping right into the fray with their groundbreaking PAL-119. They're not just peddling another temporary fix like most on the market;...

Continue Reading
CodeBoxx CrewKit Forge: Decentralizing AI Development

Updated Category News Views 71

Unboxing the Machine: CodeBoxx's Ambitious Move When you're talking about shakin' up the tech world, look no further than CodeBoxx and their CrewKit Forge. Unveiled at the Titan 100 Tampa Bay gala, this AI software factory is a beast—a one-meter cube ready to replace a battalion of developers. Imagine not the sterile data centers but this thing chilling in your office,...

Continue Reading
Abracon Unveils Engineer-Focused Website Features

Updated Category News Views 59

Pushing the Needle in Digital Engagement Some days, the market talk brews hotter than a Texas barbecue, and today it’s Abracon serving up something new. They're tossing engineers a fresh digital bone with revamped website accounts. No bells or whistles, just a clean shot at making techies' lives easier as they tinker and design. It's a world where getting your hands on...

Continue Reading
Virginia Innovation Boosts Startups and Research Growth

Updated Category News Views 132

Virginia's Rising Innovation Ecosystem Virginia, a place you might not expect to hear much about in terms of innovation, is actually shaking things up and making waves on a national scale. Throwing their hat into the innovation arena, Virginia's landed itself a cozy #5 spot for its 'Innovation and Research Ecosystem,' according to Area Development's latest rankings. The...

Continue Reading
Restorative Getaways Aid Grieving Families, Offers Relief

Updated Category News Views 58

Finding Solace in Change: The Power of Stepping Away Grieving a lost child. It’s a trip to hell and back, and for many families, the journey feels endless. The press of everyday life—bills, jobs, commutes—offers no mercy. At times, stepping out of the blur might be the prime move toward healing, and that's where restorative getaways step in. Escaping the Everyday...

Continue Reading

Top 5 Most Recently Viewed Articles

KBR, Inc. Shareholders Urged to Act Before Key Deadline

Updated Category News Views 152

Critical Information for KBR, Inc. Shareholders Investors and stakeholders of KBR, Inc. (NYSE: KBR) are being reminded of an important lead plaintiff deadline approaching on November 18, 2025. This announcement aims to alert shareholders who purchased shares during the designated class period to take necessary action regarding their rights. Details of the Class Action The...

Continue Reading
BBG Opens New Office in Washington, D.C. to Expand Services

Updated Category News Views 187

BBG Expands Into Washington, D.C. with New Office DALLAS - BBG, a prominent entity in the commercial real estate valuation sector, has unveiled its newest office in Washington, D.C. This strategic establishment is spearheaded by Bruce H. Davis, Jr., MAI, SRA, who has joined BBG as the Director for the Northeast Division, bringing with him a wealth of expertise....

Continue Reading
Analyzing Clear Channel Outdoor Holdings' Q2 2025 Performance

Updated Category News Views 191

Clear Channel Outdoor Holdings, Inc. Reports Second Quarter 2025 Results Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) announced its financial results for the quarter ended June 30, 2025. The company reported a solid increase in consolidated revenue, signaling effective management strategies and growth within its advertising sectors. Financial Highlights and...

Continue Reading
Xona Strengthens Cybersecurity Solutions in APAC Region

Updated Category News Views 118

Xona Expands Cybersecurity Services Across APAC Based on recent growth and success in key global markets, leading cybersecurity company Xona Systems is deepening its commitment to provide organizations with secure access to critical infrastructure, including operational technology (OT), information technology (IT), and cloud environments. This strategic decision comes as...

Continue Reading
Leadership Transition at GSK: New Era Begins with Luke Miels

Updated Category News Views 272

Major Leadership Change at GSK plc GSK plc (NYSE: GSK) recently announced the appointment of Luke Miels as the new CEO of GSK. He is set to take over from the current CEO, Dame Emma Walmsley, officially assuming the position on January 1, 2026. Background on Luke Miels Luke has been a valuable part of the GSK team since 2017, where he initially served as the Chief...

Continue Reading